{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:01:44Z","timestamp":1788174104148,"version":"build-2803163510"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":1018,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Several molecular biomarkers are available that predict newly detected atrial fibrillation (NDAF). We aimed to identify such biomarkers that predict NDAF after an Ischaemic stroke (IS)\/Transient Ischaemic Attack (TIA) and evaluate their performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review was undertaken in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Studies of patients with IS, TIA, or both, who underwent ECG monitoring for \u2a7e24 h, which reported molecular biomarkers and frequency of NDAF after electronic searches of multiple databases were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty-one studies (76% IS, 24% IS and TIA) involving 4640 patients were included. Twelve biomarkers were identified, with cardiac biomarkers evaluated in the majority (75%) of patients. Performance measures were inconsistently reported. Among cohorts selecting high-risk individuals (12 studies), the most studied biomarkers were N-Terminal-Pro Brain Natriuretic Peptide (NT-ProBNP, five studies; C-statistics reported by three studies, 0.69\u20130.88) and Brain Natriuretic Peptide (BNP, two studies; C-statistics reported in two studies, 0.68\u20130.77). Among unselected cohorts (nine studies), the most studied biomarker was BNP (six studies; C-statistics reported in five studies, 0.75\u20130.88). Only BNP was externally validated (two studies) but using different thresholds to categorise risk of NDAF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Cardiac biomarkers appear to have modest to good discrimination for predicting NDAF, although most analyses were limited by small, heterogeneous study populations. Their clinical utility should be explored further, and this review supports the need to assess the role of molecular biomarkers in large prospective studies with standardised selection criteria, definition of clinically significant NDAF and laboratory assays.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/23969873221136927","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:14:03Z","timestamp":1670310843000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Molecular biomarkers predicting newly detected atrial fibrillation after ischaemic stroke or TIA: A systematic review"],"prefix":"10.1093","volume":"8","author":[{"given":"Kirsty","family":"Ward","sequence":"first","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Salford Care organisation, Northern Care Alliance NHS Foundation Trust, UK 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Vail","sequence":"additional","affiliation":[{"name":"Centre for Biostatistics, University of Manchester, Manchester Academic Health Science Centre, UK 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6965-1109","authenticated-orcid":false,"given":"Alan","family":"Cameron","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Katan","sequence":"additional","affiliation":[{"name":"Stroke Center\/Dept. Of Neurology University Hospital and University of Basel, Switzerland 4"},{"name":"Stroke Center\/Dept. Of Neurology University Hospital and University of Zurich, Switzerland 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK 6"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-2475","authenticated-orcid":false,"given":"Jesse","family":"Dawson","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J","family":"Smith","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Salford Care organisation, Northern Care Alliance NHS Foundation Trust, UK 1"},{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1820-8697","authenticated-orcid":false,"given":"Amit K","family":"Kishore","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Salford Care organisation, Northern Care Alliance NHS Foundation Trust, UK 1"},{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK 8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"2026012113104704000_bibr1-23969873221136927","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11883-006-0009-9","article-title":"Cardioembolic stroke","volume":"8","author":"Murtagh","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"2026012113104704000_bibr2-23969873221136927","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0404.1997.tb00307.x","article-title":"Cardioembolic infarction in the sagrat cor-Alianza hospital of Barcelona stroke registry","volume":"96","author":"Arboix","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"2026012113104704000_bibr3-23969873221136927","first-page":"383","article-title":"Risk of stroke with paroxysmal and permanent atrial fibrillation is the same","volume":"335","author":"Achanta","year":"2015","journal-title":"BMJ"},{"key":"2026012113104704000_bibr4-23969873221136927","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","article-title":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis","volume":"14","author":"Sposato","year":"2015","journal-title":"Lancet Neurol"},{"key":"2026012113104704000_bibr5-23969873221136927","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"key":"2026012113104704000_bibr6-23969873221136927","first-page":"987","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"379","author":"Hart","year":"2018","journal-title":"New Engl J Med"},{"key":"2026012113104704000_bibr7-23969873221136927","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"New Engl J Med"},{"key":"2026012113104704000_bibr8-23969873221136927","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113104704000_bibr9-23969873221136927","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"2026012113104704000_bibr10-23969873221136927","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/STROKEAHA.113.003433","article-title":"Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"45","author":"Kishore","year":"2014","journal-title":"Stroke"},{"key":"2026012113104704000_bibr11-23969873221136927","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"New Engl J Med"},{"key":"2026012113104704000_bibr12-23969873221136927","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2017.06.039","article-title":"Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population","volume":"244","author":"Ziegler","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026012113104704000_bibr13-23969873221136927","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/1573403X10666140214122633","article-title":"Cardioembolic stroke diagnosis using blood biomarkers","volume":"9","author":"Llombart","year":"2013","journal-title":"Curr Cardiol Rev"},{"key":"2026012113104704000_bibr14-23969873221136927","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026012113104704000_bibr15-23969873221136927","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000342887","article-title":"Brain natriuretic peptide as a predictor of cardioembolism in acute ischemic stroke patients: brain natriuretic peptide stroke prospective study","volume":"69","author":"Sakai","year":"2013","journal-title":"Eur Neurol"},{"key":"2026012113104704000_bibr16-23969873221136927","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/bios10090107","article-title":"B-type natriuretic peptide as a significant brain biomarker for stroke triaging using a bedside point-of-care monitoring biosensor","volume":"10","author":"Harpaz","year":"2020","journal-title":"Biosensors"},{"key":"2026012113104704000_bibr17-23969873221136927","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"2026012113104704000_bibr18-23969873221136927","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026012113104704000_bibr19-23969873221136927","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2026012113104704000_bibr20-23969873221136927","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/1747493017724624","article-title":"Differential characteristics, stroke recurrence, and predictors of covert atrial fibrillation of embolic strokes of undetermined source","volume":"13","author":"Hawkes","year":"2018","journal-title":"Int J Stroke"},{"key":"2026012113104704000_bibr21-23969873221136927","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.08.022","article-title":"Prevalence and risk factors for paroxysmal atrial fibrillation and flutter detection after cryptogenic ischemic stroke","volume":"27","author":"Carrazco","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026012113104704000_bibr22-23969873221136927","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5507\/bp.2015.019","article-title":"Paroxysmal atrial fibrillation in young cryptogenic ischemic stroke: a 3-week ECG Holter monitoring study","volume":"159","author":"Sanak","year":"2015","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"2026012113104704000_bibr23-23969873221136927","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/ijs.12126","article-title":"N-terminal pro-brain natriuretic peptide shows diagnostic accuracy for detecting atrial fibrillation in cryptogenic stroke patients","volume":"9","author":"Fonseca","year":"2014","journal-title":"Int J Stroke"},{"key":"2026012113104704000_bibr24-23969873221136927","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e31829d8773","article-title":"High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke","volume":"81","author":"Rodr\u00edguez-Y\u00e1\u00f1ez","year":"2013","journal-title":"Neurology"},{"key":"2026012113104704000_bibr25-23969873221136927","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1161\/STROKEAHA.119.025339","article-title":"Blood biomarkers of heart failure and hypercoagulation to identify atrial fibrillation\u2013related stroke","volume":"50","author":"Kneihsl","year":"2019","journal-title":"Stroke"},{"key":"2026012113104704000_bibr26-23969873221136927","doi-asserted-by":"crossref","first-page":"e1892","DOI":"10.1212\/WNL.0000000000009365","article-title":"Markers of coagulation and hemostatic activation aid in identifying causes of cryptogenic stroke","volume":"94","author":"Nahab","year":"2020","journal-title":"Neurology"},{"key":"2026012113104704000_bibr27-23969873221136927","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013830","article-title":"Coagulation markers and echocardiography predict atrial fibrillation, malignancy, or recurrent stroke after cryptogenic stroke","volume":"97","author":"Ellis","year":"2018","journal-title":"Medicine"},{"key":"2026012113104704000_bibr28-23969873221136927","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12975-020-00873-2","article-title":"Predicting atrial fibrillation with high risk of embolization with atrial strain and NT-proBNP","volume":"12","author":"Pagola","year":"2021","journal-title":"Transl Stroke Res"},{"key":"2026012113104704000_bibr29-23969873221136927","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/STROKEAHA.119.026496","article-title":"Brain natriuretic peptide and discovery of atrial fibrillation after stroke: a subanalysis of the Find-AFRANDOMISED trial","volume":"51","author":"Wasser","year":"2020","journal-title":"Stroke"},{"key":"2026012113104704000_bibr30-23969873221136927","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1871529X19666190410145501","article-title":"P wave dispersion and silent atrial fibrillation in cryptogenic stroke: the pathogenic role of inflammation","volume":"19","author":"Acampa","year":"2019","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"2026012113104704000_bibr31-23969873221136927","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5551\/jat.58420","article-title":"Atrial fibrillation after ischemic stroke detected by chest strap-style 7-day holter monitoring and the risk predictors: EDUCATE-ESUS","volume":"28","author":"Miyazaki","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"2026012113104704000_bibr32-23969873221136927","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.06.019","article-title":"A score for predicting paroxysmal atrial fibrillation in acute stroke patients: iPAB score","volume":"24","author":"Yoshioka","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026012113104704000_bibr33-23969873221136927","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.01.008","article-title":"Troponin elevation predicts atrial fibrillation in patients with stroke or transient ischemic attack","volume":"22","author":"Beaulieu-Boire","year":"2013","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"2026012113104704000_bibr34-23969873221136927","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.08.010","article-title":"Brain natriuretic peptide: a relevant marker to rule out delayed atrial fibrillation in stroke patient","volume":"22","author":"Suissa","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026012113104704000_bibr35-23969873221136927","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034351","article-title":"Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia \u2013 the Find-AF study","volume":"7","author":"Wachter","year":"2012","journal-title":"PLoS One"},{"key":"2026012113104704000_bibr36-23969873221136927","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000155640","article-title":"Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation","volume":"26","author":"Naya","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"2026012113104704000_bibr37-23969873221136927","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.038","article-title":"Troponin-I is a predictor of a delayed diagnosis of atrial fibrillation in acute ischemic stroke and transient ischemic attack","volume":"24","author":"Ward","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026012113104704000_bibr38-23969873221136927","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1468-1331.2009.02813.x","article-title":"Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack","volume":"17","author":"Okada","year":"2010","journal-title":"Eur J Neurol"},{"key":"2026012113104704000_bibr39-23969873221136927","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.amjcard.2011.12.022","article-title":"Brain natriuretic peptide levels as a predictor for new atrial fibrillation during hospitalization in patients with acute ischemic stroke","volume":"109","author":"Shibazaki","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026012113104704000_bibr40-23969873221136927","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000258679","article-title":"Troponin levels help predict new-onset atrial fibrillation in ischaemic stroke patients: a retrospective study","volume":"63","author":"Bugnicourt","year":"2010","journal-title":"Eur Neurol"},{"key":"2026012113104704000_bibr41-23969873221136927","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012769","article-title":"Biomarkers for atrial fibrillation detection after stroke: systematic review and meta-analysis","volume":"97","author":"Cameron","year":"2021","journal-title":"Neurology"},{"key":"2026012113104704000_bibr42-23969873221136927","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/STROKEAHA.107.505354","article-title":"Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers","volume":"39","author":"Montaner","year":"2008","journal-title":"Stroke"},{"key":"2026012113104704000_bibr43-23969873221136927","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/CS20150469","article-title":"The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment","volume":"130","author":"Volpe","year":"2016","journal-title":"Clin Sci"},{"key":"2026012113104704000_bibr44-23969873221136927","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004922","article-title":"Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke","volume":"90","author":"De Marchis","year":"2018","journal-title":"Neurology"},{"key":"2026012113104704000_bibr45-23969873221136927","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2022.01.042","article-title":"Measurement of midregional Pro-Atrial natriuretic peptide to discover atrial fibrillation in patients with ischemic stroke","volume":"79","author":"Schweizer","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026012113104704000_bibr46-23969873221136927","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1161\/STROKEAHA.119.026185","article-title":"Using blood biomarkers to identify atrial fibrillation-related stroke","volume":"50","author":"Kozie\u0142","year":"2019","journal-title":"Stroke"},{"key":"2026012113104704000_bibr47-23969873221136927","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/17474930211045880","article-title":"Use of risk scores for predicting new atrial fibrillation after ischemic stroke or transient ischemic attack-a systematic review","volume":"17","author":"Kishore","year":"2022","journal-title":"Int J Stroke"},{"key":"2026012113104704000_bibr48-23969873221136927","doi-asserted-by":"crossref","DOI":"10.1177\/23969873221099478","article-title":"European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin","volume":"7","author":"Rubiera","year":"2022","journal-title":"Eur Stroke J"},{"key":"2026012113104704000_bibr49-23969873221136927","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112824","article-title":"Clinical applications of natriuretic peptides in heart failure and atrial fibrillation","volume":"20","author":"Baba","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026012113104704000_bibr50-23969873221136927","doi-asserted-by":"crossref","first-page":"839398","DOI":"10.3389\/fneur.2022.839398","article-title":"Atrial cardiopathy and cryptogenic stroke","volume":"13","author":"Kato","year":"2022","journal-title":"Front Neurol"},{"key":"2026012113104704000_bibr51-23969873221136927","doi-asserted-by":"crossref","first-page":"949213","DOI":"10.3389\/fcvm.2022.949213","article-title":"Multimodal approach for the prediction of atrial fibrillation detected after stroke: SAFAS Study","volume":"9","author":"Garnier","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026012113104704000_bibr52-23969873221136927","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/2396987319837089","article-title":"Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - the Nordic Atrial Fibrillation and stroke (NOR-FIB) study: Rationale and design","volume":"4","author":"Ratajczak-Tretel","year":"2019","journal-title":"Eur Stroke J"},{"key":"2026012113104704000_bibr53-23969873221136927","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.038","article-title":"Pathophysiology and risk of atrial fibrillation detected after ischemic stroke (PARADISE): a translational, integrated, and transdisciplinary approach","volume":"27","author":"Paquet","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026012113104704000_bibr54-23969873221136927","article-title":"Midregional proatrial natriuretic peptide to guide secondary stroke prevention (MOSES)","author":"Katan","year":"2019"}],"container-title":["European Stroke Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23969873221136927","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23969873221136927","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/8\/1\/125\/64652819\/23969873221136927.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/8\/1\/125\/64652819\/23969873221136927.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:12:22Z","timestamp":1769019142000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/esj\/article\/8\/1\/125\/8269091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1177\/23969873221136927","relation":{},"ISSN":["2396-9873","2396-9881"],"issn-type":[{"value":"2396-9873","type":"print"},{"value":"2396-9881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,3,1]]}}}